Published in Cancer on November 15, 1993
Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg (2005) 2.28
Ex vivo pig training model for esophageal endoscopic submucosal dissection (ESD) for endoscopists with experience in gastric ESD. Surg Endosc (2012) 1.00
Surgical treatment of superficial esophageal cancer. Langenbecks Arch Surg (2006) 0.99
Long-term outcome after endoscopic submucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study. Gut Liver (2014) 0.97
Assessment of cervical lymph node metastasis in esophageal carcinoma using ultrasonography. Ann Surg (1999) 0.93
Combined radiochemotherapy for postoperative recurrence of oesophageal cancer. Gut (1995) 0.90
Endoscopic mucosal resection using a cap-fitted panendoscope and endoscopic submucosal dissection as optimal endoscopic procedures for superficial esophageal carcinoma. Surg Endosc (2011) 0.89
Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA. Br J Cancer (2000) 0.86
A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. Jpn J Clin Oncol (2009) 0.86
Endoscopic and Oncologic Outcomes of Endoscopic Resection for Superficial Esophageal Neoplasm. Gut Liver (2015) 0.81
Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas. Eur Radiol (2011) 0.78
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma. BMC Cancer (2014) 0.77
Prognostic factors in patients with submucosal carcinoma of the oesophagus. Br J Cancer (2000) 0.77
Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery. World J Gastroenterol (2016) 0.75
Three-field lymph node dissection in treating the esophageal cancer. J Thorac Dis (2016) 0.75
Ten-year experience of esophageal endoscopic submucosal dissection of superficial esophageal neoplasms in a single center. Korean J Intern Med (2016) 0.75
Esophageal Cancer: Current Options for Therapeutic Management. Gastrointest Tumors (2014) 0.75
Extent of Mediastinal Lymphadenectomy and Survival in Superficial Esophageal Squamous Cell Carcinoma. J Gastrointest Surg (2017) 0.75
Three-field lymph node dissection in esophageal cancer surgery. J Thorac Dis (2017) 0.75
Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology (2008) 5.31
Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A (1995) 4.28
Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer (1996) 3.21
Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg (1991) 3.00
A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res (1994) 2.17
Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res (1996) 1.89
Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis? Gut (1999) 1.84
Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology (1995) 1.78
Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res (2000) 1.71
Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res (1988) 1.67
Very-high-energy gamma rays from a distant quasar: how transparent is the universe? Science (2008) 1.65
The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer (1997) 1.64
E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res (1996) 1.62
Three-field lymph node dissection for esophageal cancer in elderly patients over 70 years of age. Ann Thorac Surg (2001) 1.59
Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res (1994) 1.58
Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer (2000) 1.53
p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer (1993) 1.44
Reversible change of bladder hypertrophy due to benign prostatic hyperplasia after surgical relief of obstruction. J Urol (1997) 1.44
Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer (2000) 1.44
Growth requirements of hyperthermophilic sulfur-dependent heterotrophic archaea isolated from a shallow submarine geothermal system with reference to their essential amino acids. Appl Environ Microbiol (1994) 1.44
c-erbB-2 gene product directly associates with beta-catenin and plakoglobin. Biochem Biophys Res Commun (1995) 1.40
Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303. Science (2006) 1.40
Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology (1997) 1.37
Intramural metastasis of thoracic esophageal carcinoma. Int J Cancer (1992) 1.33
Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus (2011) 1.33
Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction: a preliminary report. Urology (1996) 1.33
Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells. Oncogene (1996) 1.30
Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology (2000) 1.24
Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis (1999) 1.23
Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Lung Cancer (2000) 1.20
MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes. Oncogene (2011) 1.20
Immunohistochemical detection of K-sam protein in stomach cancer. Clin Cancer Res (1996) 1.19
KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer. Br J Cancer (2012) 1.16
Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer (1988) 1.14
Association of plakoglobin with APC, a tumor suppressor gene product, and its regulation by tyrosine phosphorylation. Biochem Biophys Res Commun (1994) 1.13
Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody. Am J Pathol (1999) 1.13
The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene (2007) 1.11
Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1. In Vitro Cell Dev Biol Anim (2000) 1.11
Comparison of the alpha-toxin genes of Clostridium perfringens type A and C strains: evidence for extragenic regulation of transcription. Infect Immun (1993) 1.10
Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer (2013) 1.09
Carcinosarcoma of the esophagus: a twenty-case study. Jpn J Clin Oncol (1990) 1.08
Disruption of E-cadherin-mediated cell adhesion systems in gastric cancers in young patients. Jpn J Cancer Res (1999) 1.06
Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res (1985) 1.05
Lymph node metastasis in thoracic esophageal carcinoma. J Surg Oncol (1991) 1.04
Primary gastric squamous cell carcinoma in situ originating from gastric squamous metaplasia. Endoscopy (2010) 1.03
Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer. Cancer Lett (1996) 1.03
A case of small polypoid esophageal carcinoma with multidirectional differentiation, including neuroendocrine, squamous, ciliated glandular, and sarcomatous components. Arch Pathol Lab Med (2000) 1.02
Thoracic esophageal carcinoma above the carina: a more formidable adversary? J Surg Oncol (1997) 1.01
Clinical implications of immunoreactivity of thymidylate synthase and dihydropyrimidine dehydrogenase in gastric cancer treated with oral fluoropyrimidine (S-1). Study Group of S-1 for Gastric Cancer. Int J Oncol (2000) 1.01
Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer (1995) 1.01
Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg (2001) 1.00
Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors. Biochimie (2005) 1.00
Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue in the thymus of a patient with pulmonary amyloid nodules. Jpn J Clin Oncol (2000) 1.00
KRAS mutations detected by the amplification refractory mutation system-Scorpion assays strongly correlate with therapeutic effect of cetuximab. Br J Cancer (2011) 1.00
Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am J Pathol (2001) 1.00
Metastatic esophageal tumors from distant primary lesions: report of three esophagectomies and study of 1835 autopsy cases. Jpn J Clin Oncol (1997) 1.00
Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg (2001) 0.98
Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int J Cancer (1993) 0.98
Effects of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice. Cancer Res (1984) 0.98
Superficial esophageal carcinoma. Surgical treatment and the results. Cancer (1990) 0.97
Clinical implications of microsatellite instability in colorectal cancers. Cancer (1996) 0.97
Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma. Cancer Res (2001) 0.97
Intraobserver and interobserver variance in the measurement of ultrasound-estimated bladder weight. Ultrasound Med Biol (1998) 0.97
Extra-tumor perineural invasion predicts postoperative development of peritoneal dissemination in pancreatic ductal adenocarcinoma. Anticancer Res (2001) 0.96
Detection of aberrant crypt foci by magnifying colonoscopy. Gastrointest Endosc (1997) 0.96
DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis. Cancer Lett (1998) 0.96
Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int (2001) 0.96
Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res (2001) 0.96
Human CDC45 protein binds to minichromosome maintenance 7 protein and the p70 subunit of DNA polymerase alpha. Eur J Biochem (1999) 0.96
Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut (2000) 0.95
Presence of Streptococcus DNA sequence in surgical specimens of gastric cancer. Jpn J Cancer Res (1995) 0.95
Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Eur J Surg Oncol (2005) 0.95
High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms. Lung Cancer (2000) 0.94
Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification. Ann Oncol (2013) 0.93
Overexpression of sialyl Lewis x antigen is associated with formation of extratumoral venous invasion and predicts postoperative development of massive hepatic metastasis in cases with pancreatic ductal adenocarcinoma. Pathobiology (2001) 0.93
New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus. Pathol Int (2000) 0.92
Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br J Cancer (2004) 0.92
Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study. Dis Esophagus (2006) 0.92
Hepatocellular carcinoma with gastrointestinal hemorrhage caused by direct tumor invasion to the duodenum. Jpn J Clin Oncol (1997) 0.91
Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod Pathol (2001) 0.91
Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis. Cancer (1995) 0.91
Macroscopic features at the deepest site of tumor penetration predicting liver metastases of colorectal cancer. Jpn J Clin Oncol (1998) 0.91
Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan. Recent Results Cancer Res (2000) 0.91
The effects of epidural block on the distribution of lymphocyte subsets and natural-killer cell activity in patients with and without pain. Anesth Analg (2001) 0.90
Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res (1995) 0.90
Predominant presence of Streptococcus anginosus in the saliva of alcoholics. Oral Microbiol Immunol (2005) 0.90
Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection. J Surg Oncol (1996) 0.89